Mark Munson

887 total citations
20 papers, 482 citations indexed

About

Mark Munson is a scholar working on Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Mark Munson has authored 20 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 10 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Mark Munson's work include Chemical Synthesis and Analysis (7 papers), Cancer Mechanisms and Therapy (4 papers) and Computational Drug Discovery Methods (3 papers). Mark Munson is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Cancer Mechanisms and Therapy (4 papers) and Computational Drug Discovery Methods (3 papers). Mark Munson collaborates with scholars based in United States, Spain and France. Mark Munson's co-authors include George Bárány, Fernando Alberício, Carlos Garcı́a-Echeverrı́a, David Andreu, Marc Ferrer, Nuriá A. Solé, Ernest Giralt, Miquel Pons, David R. Baker and Kenneth A. Ault and has published in prestigious journals such as Journal of the American Chemical Society, Blood and The Journal of Immunology.

In The Last Decade

Mark Munson

18 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Munson United States	12	351	204	66	40	38	20	482
Fortuna Haviv United States	13	331 0.9×	236 1.2×	72 1.1×	30 0.8×	9 0.2×	24	620
Anupam Patgiri United States	9	708 2.0×	246 1.2×	119 1.8×	56 1.4×	13 0.3×	11	831
Ayumu Niida Japan	16	580 1.7×	293 1.4×	134 2.0×	42 1.1×	14 0.4×	27	867
Vanessa K. Lacey United States	10	406 1.2×	135 0.7×	32 0.5×	70 1.8×	11 0.3×	12	546
Xiucong Bao Hong Kong	12	618 1.8×	118 0.6×	120 1.8×	13 0.3×	15 0.4×	19	825
Yusuke Kamada Japan	15	497 1.4×	59 0.3×	125 1.9×	40 1.0×	37 1.0×	23	634
Maria Matson Dzebo Sweden	9	323 0.9×	84 0.4×	144 2.2×	19 0.5×	6 0.2×	11	521
Youngsook Shin United States	5	414 1.2×	320 1.6×	51 0.8×	36 0.9×	6 0.2×	7	466
Frédéric Berst Switzerland	13	374 1.1×	203 1.0×	49 0.7×	29 0.7×	10 0.3×	16	502
Adam A. Profit United States	13	521 1.5×	122 0.6×	35 0.5×	18 0.5×	4 0.1×	23	635

Countries citing papers authored by Mark Munson

Since Specialization

Citations

This map shows the geographic impact of Mark Munson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Munson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Munson more than expected).

Fields of papers citing papers by Mark Munson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Munson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Munson. The network helps show where Mark Munson may publish in the future.

Co-authorship network of co-authors of Mark Munson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Munson. A scholar is included among the top collaborators of Mark Munson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Munson. Mark Munson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lim, Sungtaek, Robert H. Barker, Yong Mi Choi-Sledeski, et al.. (2020). Brain Penetrable Inhibitors of Ceramide Galactosyltransferase for the Treatment of Lysosomal Storage Disorders. ACS Medicinal Chemistry Letters. 11(10). 2010–2016. 12 indexed citations

Li, Yi, et al.. (2020). Selectivity in the Addition of Electron‐Deficient Radicals to the C2 Position of Indoles. European Journal of Organic Chemistry. 2020(36). 5828–5832. 13 indexed citations

Li, Yi, et al.. (2018). Amelioration of mechanism-based inactivation of CYP3A4 by a H-PGDS inhibitor. Bioorganic & Medicinal Chemistry Letters. 28(18). 3046–3049. 3 indexed citations

Li, Yi, et al.. (2018). Decreasing the CYP2D6 contribution to metabolism of a CK1ε inhibitor. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3681–3684. 3 indexed citations

Munson, Mark, et al.. (2015). Lead optimization attrition analysis (LOAA): a novel and general methodology for medicinal chemistry. Drug Discovery Today. 20(8). 978–987. 11 indexed citations

Robinson, John, et al.. (2011). The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease. Cellular Immunology. 272(2). 200–213. 38 indexed citations

Wright, Dale, Stefan Groß, John Robinson, et al.. (2009). Inhibition of T cell function in vitro and in vivo using small molecule antagonists of PIM kinases (35.33). The Journal of Immunology. 182(Supplement_1). 35.33–35.33. 1 indexed citations

Groß, Stefan, John Robinson, Shelley Allen, et al.. (2008). Characterization of the Effects of Pim Kinase Inhibition on Multiple Oncogene-Driven Cell Lines. Blood. 112(11). 2662–2662. 1 indexed citations

Wright, Dale, Shannon L. Winski, Deborah Anderson, et al.. (2006). ARRY-797, a Potent and Selective Inhibitor of p38 Map Kinase, Inhibits LPS-Induced IL-6 and In Vivo Growth of RPMI-8226 Human Multiple Myeloma Cells.. Blood. 108(11). 3478–3478.

10.

Andreu, David, Fernando Alberício, Nuriá A. Solé, et al.. (2003). Formation of Disulfide Bonds in Synthetic Peptides and Proteins. Humana Press eBooks. 35. 91–170. 86 indexed citations

11.

Munson, Mark, Adam Cook, John A. Josey, & Chang Rao. (1998). An efficient high-speed synthetic route to amino-substituted thiazolidinone libraries. Tetrahedron Letters. 39(40). 7223–7226. 24 indexed citations

12.

Han, Yongxin, Mark Munson, Charles A. Minor, et al.. (1996). Preparation and Applications of Xanthenylamide (XAL) Handles for Solid-Phase Synthesis ofC-Terminal Peptide Amides under Particularly Mild Conditions¹^-³. The Journal of Organic Chemistry. 61(18). 6326–6339. 32 indexed citations

13.

Mayer, John P., et al.. (1995). An alternative solid-phase approach to C1-oxytocin. Tetrahedron Letters. 36(41). 7387–7390. 24 indexed citations

14.

Munson, Mark. (1994). Events and trends in metal and mineral commodities. JOM. 46(4). 30–36. 2 indexed citations

15.

Munson, Mark. (1993). Events and trends in metal and mineral commodities. JOM. 45(4). 22–28. 1 indexed citations

16.

Munson, Mark & George Bárány. (1993). Synthesis of .alpha.-conotoxin SI, a bicyclic tridecapeptide amide with two disulfide bridges: illustration of novel protection schemes and oxidation strategies. Journal of the American Chemical Society. 115(22). 10203–10210. 49 indexed citations

17.

Munson, Mark, Carlos Garcı́a-Echeverrı́a, Fernando Alberício, & George Bárány. (1992). S-2,4,6-trimethoxybenzyl (Tmob): a novel cysteine protecting group for the N.alpha.-(9-fluorenylmethoxycarbonyl) (Fmoc) strategy of peptide synthesis. The Journal of Organic Chemistry. 57(11). 3013–3018. 41 indexed citations

18.

Munson, Mark, et al.. (1992). ChemInform Abstract: S‐2,4,6‐Trimethoxybenzyl (Tmob): A Novel Cysteine Protecting Group for the Nα‐9‐Fluorenylmethoxycarbonyl (Fmoc) Strategy of Peptide Synthesis.. ChemInform. 23(45). 3 indexed citations

19.

Alberício, Fernando, Carlos Garcı́a-Echeverrı́a, Mark Munson, et al.. (1991). Cyclization of disulfide‐containing peptides in solid‐phase synthesis^†. International journal of peptide & protein research. 37(5). 402–413. 89 indexed citations

20.

Bagwell, C. Bruce, et al.. (1989). A simple and rapid method for determining the linearity of a flow cytometer amplification system. Cytometry. 10(6). 689–694. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact